Molecular evaluation of SARS-CoV-2 in post-vaccinated patients of Malakand division Khyber Pakhtunkhwa
Abstract
Coronavirus
disease
(COVID-19)
is
one
of
the
epidemic
diseases
caused
by
SARS-CoV-2
virus.
The
priority
health
community
development
various
reliable
vaccinations
to
combat
COVID-19
pandemic.
Some
vaccines
have
been
developed
Covid-19
pandemic
and
humans
allowed
use.
However,
vaccinated
people
had
frequent
infections
in
many
areas.
purpose
this
study
find
out
efficacy
vaccine
Malakand
Division.
A
total
500
samples
were
collected
from
infected
subjects
through
nasopharyngeal
swabs.
then
categorized
based
on
vaccination
type
efficacy.
RNA
was
extracted
subjected
RT-PCR
for
detection
SARS-CoV-2.
Out
individuals,
173
positive.
rate
recurrent
high
among
all
subjects.
most
effective
Pfizer
BioNTech
with
an
efficiency
85%.
remaining
such
as
Moderna
showed
75%,
Sputnik-V
(73%),
AstraZeneca
(72%),
CoronaVac-SinoVac
(60%),
Sinopharm
BBIBP
(55%)
Cansino
Vaccine
(50%).
concludes
that
tested
can
be
recommended
minimize
risk
infection.
Research Square (Research Square), Год журнала: 2023, Номер unknown
Опубликована: Ноя. 10, 2023
Язык: Английский